Cargando…
P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA
Autores principales: | Zanwar, S., Abeykoon, J., Castillo, J., Durot, E., Kastritis, E., Uppal, E., Morel, P., Tawfiq, R., Montes, L., Paludo, J., Sarosiek, S., Kumar, S., Ogunbiyi, O., Cornillet-Lefebvre, P., Kyle, R., Delmer, A., Gertz, M., Dimopoulos, M., Ansell, S., Treon, S., D’Sa, S., Kapoor, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430342/ http://dx.doi.org/10.1097/01.HS9.0000847504.29146.b9 |
Ejemplares similares
-
P1145: OUTCOMES AND TREATMENT PATTERNS AFTER FIRST RELAPSE IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA
por: Tawfiq, R., et al.
Publicado: (2022) -
A prognostic index predicting survival in transformed Waldenström macroglobulinemia
por: Durot, Eric, et al.
Publicado: (2020) -
Treatment paradigm in Waldenström macroglobulinemia: frontline therapy and beyond
por: Zanwar, Saurabh, et al.
Publicado: (2022) -
High frequency of central nervous system involvement in transformed Waldenström macroglobulinemia
por: Durot, Eric, et al.
Publicado: (2022) -
Waldenström macroglobulinemia: biology, genetics, and therapy
por: Paludo, Jonas, et al.
Publicado: (2016)